Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

Impact · against what's priced in

The article suggests a potential 26% upside for Blue Owl Capital Corporation based on mean analyst price targets and positive earnings revisions. However, because this reflects general analyst sentiment and consensus targets rather than a specific fundamental catalyst, the immediate impact is modest.

OBDC+0.20: No priced-in read yet

Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

What matters in this story

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

What matters in this story

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

How each ticker is affected

Track these names every morning.

How Much Upside is Left in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST)?

Does AudioEye (AEYE) Have the Potential to Rally 33% as Wall Street Analysts Expect?

Wall Street Analysts Believe Replimune Group (REPL) Could Rally 26.8%: Here's is How to Trade

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet

Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

What matters in this story

Next reads from the same story arc

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

Wall Street Analysts See a 25.99% Upside in Blue Owl Capital Corporation (OBDC): Can the Stock Really Move This High?

What matters in this story

Next reads from the same story arc

How Much Upside is Left in Tarsus Pharmaceuticals (TARS)? Wall Street Analysts Think 30.78%

How each ticker is affected

Track these names every morning.

How Much Upside is Left in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST)?

Does AudioEye (AEYE) Have the Potential to Rally 33% as Wall Street Analysts Expect?

Wall Street Analysts Believe Replimune Group (REPL) Could Rally 26.8%: Here's is How to Trade

Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet